Replimune Group Ownership | Who Owns Replimune Group?
Replimune Group Ownership Summary
Replimune Group is owned by 88.42% institutional investors, 2.01% insiders, and 9.57% retail investors. Price t rowe associates inc /md/ is the largest institutional shareholder, holding 13.95% of REPL shares. US Small-Cap Growth II Equity Comp is the top mutual fund, with 5.47% of its assets in Replimune Group shares.
REPL Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Replimune Group | 88.42% | 2.01% | 9.57% |
| Sector | Healthcare Stocks | 479.67% | 11.03% | -390.70% |
| Industry | Biotech Stocks | 295.80% | 10.97% | -206.77% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Price t rowe associates inc /md/ | 10.96M | 13.95% | $132.76M |
| Baker bros. advisors lp | 11.05M | 12.07% | $102.61M |
| Blackrock | 4.71M | 7.08% | $42.42M |
| Blackrock funding, inc. /de | 5.73M | 6.26% | $53.24M |
| Redmile group | 4.66M | 5.10% | $43.34M |
| Vanguard group | 3.60M | 4.58% | $43.55M |
| Fcpm iii services b.v. | 3.91M | 4.27% | $36.32M |
| Tang capital management | 3.20M | 3.50% | $29.73M |
| Morgan stanley | 1.74M | 2.61% | $15.62M |
| Boxer capital | 1.54M | 2.31% | $13.83M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Omega fund management | 1.98M | 11.88% | $18.35M |
| Fcpm iii services b.v. | 3.91M | 9.84% | $36.32M |
| Redmile group | 4.66M | 4.61% | $43.34M |
| Ally bridge group (ny) | 528.49K | 4.09% | $4.91M |
| Velan capital investment management lp | 181.37K | 1.90% | $2.20M |
| Rosalind advisors | 260.00K | 1.61% | $3.15M |
| Bioimpact capital | 983.78K | 1.58% | $9.14M |
| Tang capital management | 3.20M | 1.50% | $29.73M |
| Sectoral asset management | 231.65K | 1.42% | $2.15M |
| Ghost tree capital | 450.00K | 1.27% | $4.05M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Boxer capital | 1.54M | 0.73% | 1.54M |
| Price t rowe associates inc /md/ | 10.96M | 0.02% | 1.08M |
| Wellington management group llp | 1.10M | 0.00% | 854.35K |
| Point72 asset management | 712.54K | 0.01% | 616.57K |
| Ally bridge group (ny) | 528.49K | 4.09% | 528.49K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| State street | 1.16M | 0.00% | -5.33M |
| Atlas venture life science advisors | - | - | -2.10M |
| Camber capital management lp | - | - | -1.35M |
| Braidwell lp | 422.89K | 0.13% | -1.04M |
| Jefferies financial group | - | - | -1.00M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Boxer capital | 1.54M | 0.73% | 1.54M | $13.83M |
| Ally bridge group (ny) | 528.49K | 4.09% | 528.49K | $4.91M |
| Nan fung trinity (hk) | 465.53K | 0.52% | 465.53K | $4.32M |
| Norges bank | 459.90K | 0.00% | 459.90K | $4.14M |
| Rosalind advisors | 260.00K | 1.61% | 260.00K | $3.15M |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -4.00 |
| Nelson, van denburg & campbell wealth management group | -8.00 |
| Global retirement partners | -32.00 |
| Creative financial designs inc /adv | -33.00 |
| Stephens consulting | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 189 | 13.17% | 80,918,624 | 7.29% | 88 | 1.08% | 86 | -2.27% | 65 | 35.42% |
| Mar 31, 2025 | 170 | 6.25% | 81,976,905 | 5.26% | 98 | 1.13% | 88 | -11.11% | 49 | 48.48% |
| Dec 31, 2024 | 91 | -38.10% | 20,304,371 | -70.81% | 25 | 0.33% | 55 | -30.38% | 17 | -56.41% |
| Sep 30, 2024 | 147 | -2.65% | 69,570,682 | -1.86% | 88 | 0.84% | 80 | -8.05% | 39 | -17.02% |
| Jun 30, 2024 | 150 | -2.60% | 70,892,178 | 6.49% | 106 | 1.07% | 86 | 3.61% | 47 | 20.51% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| US Small-Cap Growth II Equity Comp | 4.21M | 5.47% | -451.47K |
| T. Rowe Price New Horizons | 4.21M | 5.47% | -20.97K |
| Vanguard US Total Market Shares ETF | 2.02M | 2.63% | 478.00K |
| T. Rowe Price Health Sciences | 1.89M | 2.46% | 43.76K |
| Vanguard Total Stock Mkt Idx Inv | 1.74M | 2.24% | -357.90K |
| iShares Russell 2000 ETF | 1.55M | 1.99% | -29.40K |
| T. Rowe Price Integrated US Sm Gr Eq | 1.48M | 1.92% | - |
| T. Rowe Price Integrated US SmCapGrEq | 1.48M | 1.92% | - |
| T. Rowe Price New Horizons Tr-A | 1.30M | 1.69% | 21.57K |
| T. Rowe Price New Horizons Tr-Z | 1.28M | 1.66% | 1.80K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 15, 2025 | Hill Emily Luisa | Chief Financial Officer | Sell | $49.16K |
| May 20, 2025 | Astley-Sparke Philip | - | Sell | $260.17K |
| May 20, 2025 | Xynos Konstantinos | Chief Medical Officer | Sell | $64.09K |
| May 20, 2025 | Schwendenman Andrew | Chief Accounting Officer | Sell | $26.46K |
| May 20, 2025 | Patel Sushil | Chief Executive Officer | Sell | $202.35K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 3 |
| 2024 Q3 | - | 1 |
| 2024 Q2 | - | 8 |
REPL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools